Growth Metrics

Aura Biosciences (AURA) Depreciation & Amortization (CF) (2020 - 2026)

Aura Biosciences filings provide 7 years of Depreciation & Amortization (CF) readings, the most recent being $300000.0 for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) changed 0.0% to $300000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Mar 2026, down 5.92% year-over-year, with the annual reading at $1.1 million for FY2025, 5.92% down from the prior year.
  • Depreciation & Amortization (CF) hit $300000.0 in Q1 2026 for Aura Biosciences, up from $229000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $400000.0 in Q3 2023 and bottomed at $229000.0 in Q4 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $304882.4, with a median of $300000.0 recorded in 2022.
  • The largest annual shift saw Depreciation & Amortization (CF) skyrocketed 50.43% in 2022 before it decreased 25.0% in 2024.
  • Aura Biosciences' Depreciation & Amortization (CF) stood at $346000.0 in 2022, then dropped by 6.36% to $324000.0 in 2023, then fell by 7.41% to $300000.0 in 2024, then decreased by 23.67% to $229000.0 in 2025, then surged by 31.0% to $300000.0 in 2026.
  • Per Business Quant, the three most recent readings for AURA's Depreciation & Amortization (CF) are $300000.0 (Q1 2026), $229000.0 (Q4 2025), and $300000.0 (Q3 2025).